Listing Pathways and Strategy Under the Registration System

With the registration-based system now fully in place, listing in China has shifted from approval screening to disclosure-driven review, and board selection has become the first strategic decision in any IPO plan. The Main Board favours scale and stability; the STAR Market looks for hard-tech credentials and R&D intensity; ChiNext serves growth-oriented innovators; and the BSE focuses on specialised SMEs. Each board differs in financial thresholds, sector preferences and valuation levels — picking the wrong one typically costs more than twelve months of delay.

Across our mandates, we find that board choice should be derived from the nature of the business, not from queue lengths. Issuers should answer three questions first: how technologically distinctive the revenue really is, where profitability sits relative to each board’s thresholds, and what the capital-markets agenda looks like over the next three to five years. Only then should filing feasibility and timetable be assessed with counsel and auditors. A listing is not the finish line but the starting point of long-term access to capital — the earlier the pathway is planned, the higher the certainty of execution.